{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:05:56Z","timestamp":1771466756442,"version":"3.50.1"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018625","name":"Science and Technology Innovation Plan Of Shanghai Science and Technology Commission","doi-asserted-by":"publisher","award":["2022-S090-03"],"award-info":[{"award-number":["2022-S090-03"]}],"id":[{"id":"10.13039\/501100018625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p><jats:italic><jats:italic>Pneumocystis jirovecii<\/jats:italic><\/jats:italic> is frequently detected in HIV patients and individuals with compromised immune function. The clinical outcomes of these two groups differ significantly, yet the underlying reasons remain unclear, with limited studies addressing this issue. This study investigates the alterations in the pulmonary microbiota of HIV-positive and non-HIV patients following <jats:italic><jats:italic>pneumocystis jirovecii<\/jats:italic><\/jats:italic> infection.Collect bronchoalveolar lavage fluid from patients with HIV and non HIV infected <jats:italic><jats:italic>Pneumocystis jirovecii<\/jats:italic><\/jats:italic>, and compare the differences in pulmonary microbiota between the two groups.In total, 77 patients with pulmonary infection that had next generation sequencing performed on their bronchoalveolar lavage fluid and confirmed <jats:italic><jats:italic>pneumocystis jirovecii<\/jats:italic><\/jats:italic> infection were recruited in our study. Of the 77 patients with <jats:italic><jats:italic>pneumocystis jirovecii<\/jats:italic><\/jats:italic> infection, 52 were infected with HIV, and 25 were uninfected.Our findings indicate that HIV-positive patients exhibit a more diverse microbiota, predominantly characterized by viral co-infections. Specifically, 88.5% of HIV-positive patients experienced viral co-infections, primarily involving herpes viruses, followed by bacterial (61.5%) and fungal (40.4%) co-infections. In contrast, non-HIV patients predominantly exhibited bacterial co-infections (72%), followed by viral (52%) and fungal (36%) co-infections. By analyzing the next generation sequencing data of both groups, we identified statistically significant differences in viral infections (p\u2009&lt;\u20090.001), while no significant differences were observed for bacterial or fungal infections. Furthermore, among the background bacteria detected via next generation sequencing in both patient groups, 22 microbial species were commonly present. Notably, <jats:italic><jats:italic>Leptospiral virus<\/jats:italic><\/jats:italic>, <jats:italic><jats:italic>Rosette fungus<\/jats:italic><\/jats:italic>, and <jats:italic><jats:italic>Actinomycetes<\/jats:italic><\/jats:italic> were detected at higher frequencies in HIV-infected <jats:italic><jats:italic>pneumocystis jirovecii<\/jats:italic><\/jats:italic> patients, with statistically significant differences.Through comparing the pulmonary microbiota profiles of HIV-positive and non-HIV patients post-<jats:italic><jats:italic>pneumocystis jirovecii<\/jats:italic><\/jats:italic> infection, we uncovered distinct differences between the two groups, which may hold implications for guiding subsequent treatment strategies and improving clinical outcomes.<\/jats:p>","DOI":"10.1371\/journal.pone.0334220","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:28:19Z","timestamp":1760117299000},"page":"e0334220","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Differential composition of the pulmonary microbiome in HIV-positive versus HIV-negative patients with Pneumocystis jirovecii"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6237-6220","authenticated-orcid":true,"given":"Chang-Run","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Dan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Zhong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5270-9965","authenticated-orcid":true,"given":"Hai-Cheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Guo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"8","key":"pone.0334220.ref001","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/1060028016650107","article-title":"Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population","volume":"50","author":"LJ Avino","year":"2016","journal-title":"Ann Pharmacother"},{"issue":"10","key":"pone.0334220.ref002","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3201\/eid1010.030985","article-title":"Current epidemiology of Pneumocystis pneumonia","volume":"10","author":"A Morris","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"pone.0334220.ref003","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3201\/eid1903.121151","article-title":"Increasing Pneumocystis pneumonia, England, UK, 2000-2010","volume":"19","author":"R Maini","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"pone.0334220.ref004","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000487713","article-title":"Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia","volume":"96","author":"HJF Salzer","year":"2018","journal-title":"Respiration"},{"issue":"12","key":"pone.0334220.ref005","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1080\/14656566.2021.1915989","article-title":"Pneumocystis jirovecii: a review with a focus on prevention and treatment","volume":"22","author":"RB Weyant","year":"2021","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"pone.0334220.ref006","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10156-012-0453-0","article-title":"Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies","volume":"18","author":"S Tasaka","year":"2012","journal-title":"J Infect Chemother"},{"issue":"4","key":"pone.0334220.ref007","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.trsl.2012.02.005","article-title":"The microbiome of the lung","volume":"160","author":"JM Beck","year":"2012","journal-title":"Transl Res"},{"issue":"1","key":"pone.0334220.ref008","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrmicro.2016.142","article-title":"Emerging pathogenic links between microbiota and the gut-lung axis","volume":"15","author":"KF Budden","year":"2017","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"pone.0334220.ref009","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/1040841X.2021.1992345","article-title":"Emerging cellular and molecular interactions between the lung microbiota and lung diseases","volume":"48","author":"L Xiang","year":"2022","journal-title":"Crit Rev Microbiol"},{"issue":"4","key":"pone.0334220.ref010","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jaci.2015.05.044","article-title":"The airway microbiome in patients with severe asthma: Associations with disease features and severity","volume":"136","author":"YJ Huang","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"pone.0334220.ref011","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/14787210.2017.1349609","article-title":"Respiratory microbiota and lower respiratory tract disease","volume":"15","author":"M Lanaspa","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"pone.0334220.ref012","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12879-019-3712-1","article-title":"The respiratory microbiota: new insights into pulmonary tuberculosis","volume":"19","author":"S Eshetie","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"4","key":"pone.0334220.ref013","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.resinv.2022.04.002","article-title":"Pathophysiological mechanism of non-HIV Pneumocystis jirovecii pneumonia","volume":"60","author":"N Asai","year":"2022","journal-title":"Respir Investig"},{"issue":"8","key":"pone.0334220.ref014","doi-asserted-by":"crossref","first-page":"105374","DOI":"10.1016\/j.micinf.2024.105374","article-title":"Integrated analysis of microbiome and host transcriptome unveils correlations between lung microbiota and host immunity in bronchoalveolar lavage fluid of pneumocystis pneumonia patients","volume":"26","author":"L Zhang","year":"2024","journal-title":"Microbes Infect"},{"issue":"9","key":"pone.0334220.ref015","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1128\/JCM.00278-12","article-title":"Oral and airway microbiota in HIV-infected pneumonia patients","volume":"50","author":"S Iwai","year":"2012","journal-title":"J Clin Microbiol"},{"key":"pone.0334220.ref016","unstructured":"Centers for Disease Control and Prevention. Pneumocystis pneumonia. 2016."},{"issue":"3","key":"pone.0334220.ref017","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1378\/chest.08-1309","article-title":"Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates","volume":"135","author":"\u00c9 Azoulay","year":"2009","journal-title":"Chest"},{"issue":"1","key":"pone.0334220.ref018","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12890-017-0512-5","article-title":"The lung microbiome in patients with pneumocystosis","volume":"17","author":"J Kehrmann","year":"2017","journal-title":"BMC Pulm Med"},{"issue":"4","key":"pone.0334220.ref019","article-title":"Microbiomes Detected by Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing among HIV-Infected and Uninfected Patients with Pulmonary Infection","volume":"11","author":"Y Tan","year":"2023","journal-title":"Microbiol Spectr"},{"key":"pone.0334220.ref020","first-page":"123","article-title":"Management of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions","volume":"2","author":"JG Castro","year":"2010","journal-title":"HIV AIDS (Auckl)"},{"issue":"6","key":"pone.0334220.ref021","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/eri.10.42","article-title":"Pneumocystis infection in humans: diagnosis and treatment","volume":"8","author":"EJ Calder\u00f3n","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"pone.0334220.ref022","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00939-16","article-title":"Differential Macrophage Polarization from Pneumocystis in Immunocompetent and Immunosuppressed Hosts: Potential Adjunctive Therapy during Pneumonia","volume":"85","author":"V Nandakumar","year":"2017","journal-title":"Infect Immun"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0334220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:28:23Z","timestamp":1760117303000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0334220"}},"subtitle":[],"editor":[{"given":"Minal","family":"Dakhave,","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":22,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0334220","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]}}}